Risks and Triggers of Psychosis in Parkinson Disease | OMICS International| Abstract
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Alzheimers Dis Parkinsonism 2018, Vol 8(1): 413
  • DOI: 10.4172/2161-0460.1000413

Risks and Triggers of Psychosis in Parkinson Disease

Hideyuki Sawada*, Tomoko Oeda, Atsushi Umemura, Tomita Satoshi, Masayuki Kohsaka, Kwiyoung Park and Kenji Yamamoto
Department of Neurology, Utano National Hospital, Kyoto, , Japan
*Corresponding Author : Hideyuki Sawada, Department of Neurology, Utano National Hospital, 8 Ondoyamacho Narutaki, Ukyoku, Kyoto,, Japan, Tel: +81-75- 461-5121, Fax: +81 75-464-0064, Email: [email protected]

Received Date: Dec 25, 2017 / Accepted Date: Jan 03, 2018 / Published Date: Jan 10, 2018


Psychosis is a common non-motor complication in Parkinson disease, and affects the quality of life of patients and their care-givers. This psychosis is caused by intrinsic (pathological and genetic) and extrinsic factors. Pathological factors include the severity of Lewy body pathology, degeneration of cholinergic neurons and overstimulation of serotonin receptors. Genetic factors include apolipoprotein ε4, cholecystokinin genotyping, and glucocerebrosidase mutations. Extrinsic factors that trigger psychosis include systemic inflammation and medication of risky drugs. To prevent such psychosis, it is important to examine systemic infection, cease high-risk drugs, and then consider prescription of anti-psychotic drugs. This review is to discuss pathogenesis and therapeutic strategy of psychosis in Parkinson disease.

Keywords: C-reactive protein; Cognition; Psychosis; Hallucination; Delusion; Lewy body

Citation: Sawada H, Oeda T, Umemura A, Satoshi T, Kohsaka M, et al. (2018) Risks and Triggers of Psychosis in Parkinson Disease. J Alzheimers Dis Parkinsonism 8: 413. Doi: 10.4172/2161-0460.1000413

Copyright: ©2018 Sawada H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 2875
  • [From(publication date): 0-2018 - Sep 19, 2021]
  • Breakdown by view type
  • HTML page views: 2629
  • PDF downloads: 246